Kuti Baruch

Kuti Baruch

Company: Immunobrain

Job title: Vice President Research & Development


Thinking Outside the Brain: Targeting the Peripheral Immune System to Treat Alzheimer’s Disease 1:30 pm

Utilizing immune checkpoint blockade for treating neurodegeneration: the advantage of targeting the peripheral immune system Drug development and translational work of IBC-Ab002, a novel anti-PD-L1 antibody tailored for treating Alzheimer's disease Early insights from IBC-01-01, a Phase I clinical study in persons with early Alzheimer's diseaseRead more

day: Translational Track Day 2 PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.